Results 11 to 20 of about 2,317 (166)

Nebivolol

Journal of the American College of Cardiology, 2009
Münzel, Thomas, Gori, Tommaso
exaly   +2 more sources

Beneficial Effects of Nebivolol in Comparison with Atenolol on Safety and Tolerability in Essential Hypertension [PDF]

Journal of Clinical and Diagnostic Research, 2014
Introduction: Hypertension, “The silent killer” is a multifactorial disorder which is asymptomatic and if left untreated leads to lethal complications.
Vivek V. Bhosale, S.C. Inamdar, Karande V.B., Burute S.R., Murthy M.B., Ghatak A.   +5 more
doaj   +1 more source

Nitric oxide mediated the effects of nebivolol in cardiorenal syndrome [PDF]

Iranian Journal of Basic Medical Sciences, 2019
Objective(s): Despite several proposed mechanisms for the pathophysiology of cardiorenal syndrome (CRS), the exact mechanism remains unclear. Nitrosative stress has been argued as a key mechanism recently.
Guldem Mercanoglu, Semen Onder
doaj   +1 more source

The Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+]i. [PDF]

PLoS ONE, 2016
Nebivolol is known to have beta-1 blocker activity, but it was also suggested that it elicits relaxation of the peripheral arteries in part via release of nitric oxide (NO).
Peter Cseplo, Zoltan Vamos, Ivan Ivic, Orsolya Torok, Attila Toth, Akos Koller   +5 more
doaj   +1 more source

MODERN POTENTIAL IN THE TREATMENT OF METABOLIC SYNDROME PATIENTS - FOCUS ON ENDOTHELIUM

Российский кардиологический журнал, 2014
Numerous publications on the use of p-blockers in patients with arterial hypertension (AH) and metabolic syndrome (MS) have reported adverse effects of these medications on carbohydrate and lipid metabolism, as well as reduced cerebral perfusion.
V. B. Mychka, S. N. Tolstov, I. A. Salov, Yu. V. Prokhorova, E. I. Uzueva, A. L. Vertkin   +5 more
doaj   +1 more source

HEMODYNAMIC AND METABOLIC EFFECTS OF NEBIVOLOL IN LOCOMOTIVE CREW STAFF WITH NEWLY DIAGNOSED ARTERIAL HYPERTENSION

Рациональная фармакотерапия в кардиологии, 2016
Aim. To evaluate influence of long-term monotherapy with nebivolol on blood pressure (BP) (office BP; self-monitoring BP, pre-trip BP monitoring, ambulatory BP monitoring (ABPM)) and metabolic blood profile in locomotive crew staff with newly diagnosed ...
I. V. Osipova, O. N. Antropova, E. I. Bravkova, A. G. Zaltsman, T. B. Belousova, T. V. Perevozchikova, I. A. Batanina   +6 more
doaj   +1 more source

Treatment with β-blocker nebivolol ameliorates oxidative stress and endothelial dysfunction in tenofovir-induced nephrotoxicity in rats

Frontiers in Medicine, 2022
BackgroundTenofovir disoproxil fumarate (TDF), a widely prescribed component in antiretroviral regimens, has been associated with nephrotoxicity. Nebivolol is a third generation selective β-1 adrenergic receptor blocker and may protect renal structure ...
Mariana Moura Nascimento, Desiree Rita Denelle Bernardo, Ana Carolina de Bragança, Maria Heloisa Massola Shimizu, Antonio Carlos Seguro, Rildo Aparecido Volpini, Daniele Canale   +6 more
doaj   +1 more source

Investigation of a Potential Pharmacokinetic Interaction Between Nebivolol and Fluvoxamine in Healthy Volunteers

Journal of Pharmacy & Pharmaceutical Sciences, 2017
Purpose: To investigate whether fluvoxamine coadministration can influence the pharmacokinetic properties of nebivolol and its active hydroxylated metabolite (4-OH-nebivolol) and to assess the consequences of this potential pharmacokinetic interaction ...
Ana-Maria Gheldiu, Laurian Vlase, Adina Popa, Corina Briciu, Dana Muntean, Corina Bocsan, Anca Buzoianu, Marcela Achim, Ioan Tomuta, Ioana Todor, Maria Neag   +10 more
doaj   +1 more source

COMPARATIVE PHARMACOKINETICS AND EFFECT ON THE HEMODYNAMICS OF ORIGINAL AND GENERIC NEBIVOLOL IN HEALTHY VOLUNTEERS

Рациональная фармакотерапия в кардиологии, 2016
Beta-blockers are an important part of modern pharmacotherapy in cardiology. The introduction of generics into clinical practice requires clear evidence of bioequivalence to the original drug.Aim.
E. I. Bambysheva, K. V. Isaeva, M. M. Makhinova, D. T. Guranda, V. G. Belolipetskaya   +4 more
doaj   +1 more source

Photochemical Deracemization of Chromanes and its Application to the Synthesis of Enantiopure Bioactive Compounds

Angewandte Chemie, Volume 138, Issue 5, 28 January 2026.
Various substituted chromane‐2‐carboxamides were successfully deracemized by employing a chiral benzophenone (BP, 10 mol%) as photocatalyst and an achiral thiol as additive (20 mol%). The method was applied to the concise enantioselective synthesis of five active pharmaceutical ingredients.
Biki Ghosh, Maximilian Iglhaut, Daria Babushkina, Mike Pauls, Christoph Bannwarth, Thorsten Bach   +5 more
wiley   +2 more sources